P

Inventor

ZHU RUI

CN62 patents
⚠️ This page may combine multiple inventors who share the name “ZHU RUI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARROWHEAD PHARMACEUTICALS INC

16 patents
US10450565B2Oct 22, 2019

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

ARROWHEAD PHARMACEUTICALS INC15 citations94
US11203756B2Dec 21, 2021

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

ARROWHEAD PHARMACEUTICALS INC5 citations84
US10597657B2Mar 24, 2020

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

ARROWHEAD PHARMACEUTICALS INC6 citations83
US10780108B2Sep 22, 2020

RNAi agents for Hepatitis B virus infection

ARROWHEAD PHARMACEUTICALS INC5 citations82
US11884920B2Jan 30, 2024

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

ARROWHEAD PHARMACEUTICALS INC2 citations73
US10995335B2May 4, 2021

RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use

ARROWHEAD PHARMACEUTICALS INC3 citations73
US11590156B2Feb 28, 2023

RNAi agents for hepatitis B virus infection

ARROWHEAD PHARMACEUTICALS INC2 citations72
US11517584B2Dec 6, 2022

RNAi agents for Hepatitis B virus infection

ARROWHEAD PHARMACEUTICALS INC2 citations72
US11214801B2Jan 4, 2022

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

ARROWHEAD PHARMACEUTICALS INC3 citations72
US11597701B2Mar 7, 2023

Integrin ligands and uses thereof

ARROWHEAD PHARMACEUTICALS INC2 citations68
US12365899B2Jul 22, 2025

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

ARROWHEAD PHARMACEUTICALS INC0 citations62
US11214802B2Jan 4, 2022

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

ARROWHEAD PHARMACEUTICALS INC0 citations61
US10590416B2Mar 17, 2020

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

ARROWHEAD PHARMACEUTICALS INC1 citations61
US11492624B2Nov 8, 2022

RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1

ARROWHEAD PHARMACEUTICALS INC1 citations60
US12534728B2Jan 27, 2026

RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of use

ARROWHEAD PHARMACEUTICALS INC0 citations57
US12221610B2Feb 11, 2025

RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use

ARROWHEAD PHARMACEUTICALS INC0 citations50

STANFORD RES INST INT

4 patents

MICROSOFT TECHNOLOGY LICENSING LLC

4 patents

LEVINE PETER ALAN

3 patents

UNIV NORTH CHINA ELECTRIC POWER

2 patents

CHENG LIMING

2 patents

UNIV TONGJI

2 patents

ZHU RUI

2 patents

SENSORS UNLIMITED INC

2 patents

SARNOFF CORP

1 patent

SRINIVASAN SRIDHAR

1 patent

UNIV CALIFORNIA

1 patent

PEOPLE?S LIBERATION ARMY ARMY ACAD OF ARMORED FORCES

1 patent

NINGDE AMPEREX TECHNOLOGY LTD

1 patent

CHANGZHOU INST TECHNOLOGY

1 patent

YULONG COMPUTER TELECOMMUNICATION SCIENTIFIC SHENZHEN CO LTD

1 patent

FUYAO GLASS IND GROUP CO LTD

1 patent

ZHANG BO

1 patent

TENCENT TECH SHENZHEN CO LTD

1 patent

HUAWEI CLOUD COMPUTING TECH CO LTD

1 patent

KONKA GROUP CO LTD

1 patent

LIU YAOZHONG

1 patent

Showing the top 50 of 62 patents by PatentIndex Score.